Sphingosine Kinase Type 1 Inhibitors, Compositions and Processes for Using Same
Virginia Commonwealth University
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/048,638, filed Apr 29, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,314,151 | Sphingosine Kinase Type 1 Inhibitors, and Processes for Using Same In force · High confidence UsedRemaining | Enzo Therapeutics, Inc. | In force | High confidence | ||
| US 8,372,888 | Sphingosine Kinase Type 1 Inhibitors, Compositions and Processes for Using Same In force · High confidence | Virginia Commonwealth University | In force | High confidence | ||
| US 9,388,121 | Sphingosine Kinase Type 1 Inhibitors In force · High confidence | Enzo Therapeutics, Inc. and Virginia Commonwealth University | In force | High confidence | ||
| US 9,974,758 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof In force · High confidence | Enzo Therapeutics, Inc. and Virginia Commonwealth University | In force | High confidence | ||
| US 10,166,204 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof In force · Medium confidence | Enzo Therapeutics, Inc. and Virginia Commonwealth University | In force | Medium confidence | ||
| US 10,456,370 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof In force · Medium confidence | Enzo Therapeutics, Inc. and Virginia Commonwealth University | In force | Medium confidence | ||
| US 10,624,863 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof In force · Medium confidence | Enzo Therapeutics, Inc. and Virginia Commonwealth University | In force | Medium confidence | ||
| US 10,945,971 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof In force · Medium confidence | Enzo Therapeutics, Inc. | In force | Medium confidence | ||
| US 11,737,992 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof In force · High confidence | Enzo Therapeutics, Inc. and Virginia Commonwealth University | In force | High confidence |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Virginia Commonwealth University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.